Income Statement
Balance Sheet
Cash Flow
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Selling General And Administration | 500,530 | -- | 355,975 | 425,125 | 369,767 |
| General And Administrative Expense | 500,530 | -- | 355,975 | 425,125 | 369,767 |
| Other Operating Expenses | 157,555 | -- | 39,678 | 27,084 | 29,330 |
| Operating Expense | 658,085 | -- | 395,653 | 452,209 | 399,097 |
| Operating Income | -658,085 | -- | -395,653 | -452,209 | -399,097 |
| EBIT | -658,085 | -- | -395,653 | -452,209 | -399,097 |
| Interest Income | 0.00 | -- | 195.00 | 293.00 | 3,206 |
| Interest Income Non Operating | 0.00 | -- | 195.00 | 293.00 | 3,206 |
| Net Interest Income | 0.00 | -- | 195.00 | 293.00 | 3,206 |
| Other Income Expense | 48,774 | -- | 41,206 | 198,344 | -32,400 |
| Other Non Operating Income Expenses | 141,039 | -- | 54,089 | 231,911 | 70,103 |
| Special Income Charges | 0.00 | -- | 0.00 | 0.00 | 16,622 |
| Gain On Sale Of Security | -92,265 | -- | -12,883 | -33,567 | -119,125 |
| Pretax Income | -609,311 | -- | -354,252 | -253,572 | -428,291 |
| Tax Effect Of Unusual Items | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -609,311 | -- | -110,252 | -253,572 | -428,291 |
| Net Income From Continuing Operation Net Minority Interest | -609,311 | -- | -110,252 | -253,572 | -428,291 |
| Net Income Including Noncontrolling Interests | -609,311 | -- | -110,252 | -253,572 | -428,291 |
| Net Income Common Stockholders | -609,311 | -- | -110,252 | -253,572 | -428,291 |
| Net Income | -609,311 | -- | -110,252 | -253,572 | -428,291 |
| EBITDA | -658,085 | -- | -395,653 | -452,209 | -399,097 |
| Normalized EBITDA | -565,820 | -- | -382,770 | -418,642 | -296,594 |
| Basic EPS | -0.01 | -- | -- | -0.01 | -0.01 |
| Diluted EPS | -0.01 | -- | -- | -0.01 | -0.01 |
| Basic Average Shares | 92.9M | -- | -- | 46.3M | 46.3M |
| Diluted Average Shares | 92.9M | -- | -- | 46.3M | 46.3M |
| Total Unusual Items | -92,265 | -- | -12,883 | -33,567 | -102,503 |
| Total Unusual Items Excluding Goodwill | -92,265 | -- | -12,883 | -33,567 | -102,503 |
| Tax Rate For Calcs | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Normalized Income | -517,046 | -- | -97,369 | -220,005 | -325,788 |
| Diluted NI Availto Com Stockholders | -609,311 | -- | -110,252 | -253,572 | -428,291 |
| Gain On Sale Of Ppe | 0.00 | -- | 0.00 | 0.00 | 16,622 |
| Insurance And Claims | 0.00 | -- | 10,779 | 10,779 | 10,779 |
| Net Income Continuous Operations | -609,311 | -- | -110,252 | -253,572 | -428,291 |
| Net Non Operating Interest Income Expense | 0.00 | -- | 195.00 | 293.00 | 3,206 |
| Other Gand A | 425,176 | -- | 290,780 | 299,139 | 265,878 |
| Rent And Landing Fees | 16,031 | -- | 14,765 | 16,031 | 16,030 |
| Rent Expense Supplemental | 16,031 | -- | 14,765 | 16,031 | 16,030 |
| Salaries And Wages | 59,323 | -- | 39,651 | 99,176 | 77,080 |
| Total Expenses | 658,085 | -- | 395,653 | 452,209 | 399,097 |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 4.2M | -- | 34,389 | 180,710 | 203,579 |
| Cash Cash Equivalents And Short Term Investments | 4.5M | -- | 75,439 | 246,643 | 303,079 |
| Cash Financial | 4.2M | -- | 34,389 | 180,710 | 203,579 |
| Other Short Term Investments | 275,088 | -- | 41,050 | 65,933 | 99,500 |
| Accounts Receivable | -- | -- | 64,755 | -- | -- |
| Receivables | 147,373 | -- | 64,755 | 359,154 | 110,816 |
| Prepaid Assets | 228,979 | -- | 121,228 | 91,244 | 104,657 |
| Current Assets | 4.8M | -- | 261,422 | 697,041 | 518,552 |
| Net PPE | 16.7M | 16.4M | 16.1M | 15.8M | 14.6M |
| Investments And Advances | 232,497 | -- | -- | -- | -- |
| Total Non Current Assets | 16.9M | -- | 16.1M | 15.8M | 14.6M |
| Total Assets | 21.7M | -- | 16.4M | 16.5M | 15.2M |
| Accounts Payable | 504,122 | -- | 1.3M | 1.2M | 218,540 |
| Payables | 611,161 | -- | 1.3M | 1.2M | 218,540 |
| Payables And Accrued Expenses | 611,161 | -- | 1.3M | 1.2M | 218,540 |
| Other Current Liabilities | 956,458 | -- | 92,535 | 117,055 | 223,549 |
| Current Liabilities | 1.6M | -- | 1.4M | 1.3M | 442,089 |
| Total Non Current Liabilities Net Minority Interest | 140,000 | -- | 140,000 | 384,000 | 384,000 |
| Total Liabilities Net Minority Interest | 1.7M | -- | 1.5M | 1.7M | 826,089 |
| Common Stock | 29.7M | -- | 23.6M | 23.5M | 22.8M |
| Capital Stock | 29.7M | -- | 23.6M | 23.5M | 22.8M |
| Additional Paid In Capital | 1.4M | -- | 996,518 | 947,628 | 914,297 |
| Retained Earnings | -11.2M | -- | -9.7M | -9.6M | -9.4M |
| Common Stock Equity | 20.0M | -- | 14.9M | 14.8M | 14.3M |
| Stockholders Equity | 20.0M | -- | 14.9M | 14.8M | 14.3M |
| Total Equity Gross Minority Interest | 20.0M | -- | 14.9M | 14.8M | 14.3M |
| Total Capitalization | 20.0M | -- | 14.9M | 14.8M | 14.3M |
| Net Tangible Assets | 20.0M | -- | 14.9M | 14.8M | 14.3M |
| Tangible Book Value | 20.0M | -- | 14.9M | 14.8M | 14.3M |
| Working Capital | 3.3M | -- | -1.1M | -609,441 | 76,463 |
| Invested Capital | 20.0M | -- | 14.9M | 14.8M | 14.3M |
| Share Issued | 139.9M | -- | 56.1M | 54.7M | 46.3M |
| Ordinary Shares Number | 139.9M | -- | 56.1M | 54.7M | 46.3M |
| Available For Sale Securities | 232,497 | -- | -- | -- | -- |
| Duefrom Related Parties Current | 92,931 | -- | -- | 258,554 | 27,567 |
| Dueto Related Parties Current | 107,039 | -- | 32,102 | 0.00 | 0.00 |
| Investmentin Financial Assets | 232,497 | -- | -- | -- | -- |
| Non Current Deferred Liabilities | 140,000 | -- | 140,000 | 384,000 | 384,000 |
| Non Current Deferred Taxes Liabilities | 140,000 | -- | 140,000 | 384,000 | 384,000 |
| Non Current Prepaid Assets | -- | -- | 37,968 | 47,868 | 62,868 |
| Taxes Receivable | 54,442 | -- | -- | 100,600 | 83,249 |
| Line Item | Q4 2025Oct 31, 2025 | Q3 2025Jul 31, 2025 | Q2 2025Apr 30, 2025 | Q1 2025Jan 31, 2025 | Q4 2024Oct 31, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -1.4M | -- | -145,351 | -270,285 | -866,542 |
| Cash Flow From Continuing Operating Activities | -1.4M | -- | -145,351 | -270,285 | -866,542 |
| Stock Based Compensation | 59,323 | -- | 39,651 | 99,176 | 77,080 |
| Change In Working Capital | -774,512 | -- | 180,887 | 77,038 | -614,884 |
| Change In Receivables | -10,287 | -- | 72,674 | -26,613 | -47,679 |
| Change In Payables And Accrued Expense | -559,147 | -- | -115,630 | 311,963 | -119,008 |
| Other Non Cash Items | -128,093 | -- | -24,520 | -226,494 | -2,950 |
| Capital Expenditure | -45,691 | -- | -133,896 | -518,584 | -280,932 |
| Purchase Of PPE | -- | -- | -- | -518,584 | -- |
| Net PPE Purchase And Sale | -45,691 | -- | -- | -518,584 | -- |
| Sale Of Investment | 10,190 | -- | -92,041 | -71,059 | 335,313 |
| Net Investment Purchase And Sale | 10,190 | -- | -92,041 | -71,059 | 335,313 |
| Investing Cash Flow | -35,501 | -- | -111,996 | -503,584 | 54,381 |
| Cash Flow From Continuing Investing Activities | -35,501 | -- | -111,996 | -503,584 | 54,381 |
| Issuance Of Debt | -- | -- | -- | -- | 0.00 |
| Net Issuance Payments Of Debt | -- | -- | -- | -- | 0.00 |
| Issuance Of Capital Stock | 5.5M | -- | 111,026 | 751,000 | 0.00 |
| Net Common Stock Issuance | 5.5M | -- | 111,026 | 751,000 | 0.00 |
| Financing Cash Flow | 5.5M | -- | 111,026 | 751,000 | 0.00 |
| Cash Flow From Continuing Financing Activities | 5.5M | -- | 111,026 | 751,000 | 0.00 |
| Changes In Cash | 4.1M | -- | -146,321 | -22,869 | -812,161 |
| Beginning Cash Position | 92,557 | -- | 180,710 | 203,579 | 1.0M |
| End Cash Position | 4.2M | -- | 34,389 | 180,710 | 203,579 |
| Free Cash Flow | -1.4M | -- | -279,247 | -788,869 | -1.1M |
| Income Tax Paid Supplemental Data | 0.00 | -- | 0.00 | 0.00 | 0.00 |
| Interest Paid Supplemental Data | 0.00 | -- | 2,316 | 0.00 | 0.00 |
| Capital Expenditure Reported | -- | -- | -- | -- | -- |
| Change In Prepaid Assets | -205,078 | -- | 223,843 | -208,312 | -448,197 |
| Common Stock Issuance | 5.5M | -- | 111,026 | 751,000 | 0.00 |
| Gain Loss On Sale Of PPE | -- | -- | 0.00 | 0.00 | -- |
| Long Term Debt Issuance | -- | -- | -- | -- | 0.00 |
| Net Income From Continuing Operations | -609,311 | -- | -110,252 | -253,572 | -428,291 |
| Net Long Term Debt Issuance | -- | -- | -- | -- | 0.00 |
| Net Other Investing Changes | -- | -- | 113,941 | -- | -- |
| Operating Gains Losses | 0.00 | -- | 0.00 | 0.00 | -- |
| Unrealized Gain Loss On Investment Securities | 92,265 | -- | 12,883 | 33,567 | 119,125 |